Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 6Liver Neoplasms 2Prostatic Neoplasms 1Liver Diseases 1Liver Abscess 1Carcinoma 1Adenoma 1

Interventions

Sorafenib 42Bevacizumab 16Oxaliplatin 13Radiosurgery 10Gemcitabine 10Doxorubicin 10Capecitabine 10Leucovorin 9Hepatectomy 9Fluorouracil 9Cisplatin 9Radiofrequency Ablation 8Nivolumab 8pembrolizumab 7Drug Therapy 7Carboplatin 7Irinotecan 6Cryosurgery 6Talaporfin 5Mitomycin 5Everolimus 5Erlotinib Hydrochloride 5Electroporation 5spartalizumab 4Sunitinib 4Melphalan 4Ipilimumab 4Epirubicin 4Embolization, Therapeutic 4regorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Liver Neoplasms × gadolinium ethoxybenzyl DTPA × Clear all
NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

University of California, San Diego

Phase 4 Completed
79 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01043523 2016-11-28

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Bayer

Completed
52 enrolled 27 charts
Gastrointestinal

Adenoma, Carcinoma, Carcinoma, Hepatocellular, Liver Abscess, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡